{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:39Z","timestamp":1790890359390,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"OsloMet - Oslo Metropolitan University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic disrupted global tuberculosis (TB) control efforts, leading to a surge in TB-related excess mortality, particularly in low- and middle-income countries. Pandemic mitigation measures, such as lockdowns, reallocation of healthcare resources, and reduced access to diagnosis and treatment, contributed to delayed TB care and disease progression. Quantifying this collateral damage is crucial to bolstering health system resilience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We estimated country-level excess TB mortality between 2020 and 2023 using annual TB mortality data reported by the World Health Organization (WHO). Our approach leverages the SubEpiPredict toolbox of the ensemble n-sub-epidemic modeling framework, calibrated to pre-pandemic trends (2010\u20132019) to forecast expected TB deaths in the absence of COVID-19 disruptions. We selected the best-fitting model based on AICc and compared projected and reported deaths to quantify excess mortality, incorporating both normal and Poisson error structures. We further examined associations between excess TB mortality and country-level indicators, including the COVID-19 Stringency Index, Global Health Security (GHS) Index, and Socio-demographic Index (SDI). It is also noteworthy that for each estimate of excess TB deaths, we provide an associated uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our global estimate of 755,876 excess TB deaths (95%CI: 591,099 to 965,015) aligns closely with the WHO estimate of approximately 700,000 excess deaths. Therefore, it can be estimated a global relative excess mortality of 12.8% (95%CI: 11.6% to 14.2%), compared to the WHO estimate of 14.6% (95% CI: 5.9% to 26.7%). We found substantial geographic heterogeneity, with the highest TB excess mortality rates observed in southern Africa, South Asia, and parts of South America. Countries with high GHS or SDI scores did not necessarily exhibit lower excess TB mortality, suggesting that pandemic-specific disruptions and competing priorities may have overridden structural advantages. Weak-to-moderate correlations were observed between excess mortality and pandemic stringency, peaking in 2021 and waning by 2022, possibly reflecting health system adaptation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study presents a systematic, model-based analysis of global excess TB mortality during the COVID-19 pandemic, emphasizing disparities in pandemic response impacts across countries. The findings highlight the need for integrated and resilient public health systems capable of maintaining essential services amid global crises. Our methodology can support real-time monitoring of collateral effects of pandemics on endemic diseases and guide strategic investments in TB surveillance and care continuity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-24858-8","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:17:59Z","timestamp":1761905879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global excess tuberculosis mortality during COVID-19: a country-level modeling study of policy and development correlates"],"prefix":"10.1186","volume":"25","author":[{"given":"Hamed","family":"Karami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenn-Erik","family":"Mamelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Chowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"24858_CR1","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1007\/s11033-020-05413-7","volume":"47","author":"B Acharya","year":"2020","unstructured":"Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, et al. Advances in diagnosis of tuberculosis: an update into molecular diagnosis of mycobacterium tuberculosis. Mol Biol Rep. 2020;47:4065\u201375.","journal-title":"Mol Biol Rep"},{"key":"24858_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00350","volume":"7","author":"M De Martino","year":"2019","unstructured":"De Martino M, Lodi L, Galli L, Chiappini E. Immune response to mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019;7:350.","journal-title":"Front Pediatr"},{"issue":"11","key":"24858_CR3","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/pathogens11111228","volume":"11","author":"M Coleman","year":"2022","unstructured":"Coleman M, Martinez L, Theron G, Wood R, Marais B. Mycobacterium tuberculosis transmission in high-incidence settings\u2013new paradigms and insights. Pathogens. 2022;11(11):1228.","journal-title":"Pathogens"},{"key":"24858_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tube.2019.05.003","volume":"117","author":"B Patterson","year":"2019","unstructured":"Patterson B, Wood R. Is cough really necessary for TB transmission? Tuberculosis. 2019;117:31\u20135.","journal-title":"Tuberculosis"},{"key":"24858_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijid.2019.06.006","volume":"86","author":"A Shaikh","year":"2019","unstructured":"Shaikh A, Sriraman K, Vaswani S, Oswal V, Mistry N. Detection of Mycobacterium tuberculosis RNA in bioaerosols from pulmonary tuberculosis patients. Int J Infect Dis. 2019;86:5\u201311.","journal-title":"Int J Infect Dis"},{"key":"24858_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.156970","volume":"843","author":"R Verma","year":"2022","unstructured":"Verma R, Moreira FMF, do Prado Morais AO, Walter KS, Dos Santos PCP, Kim E, et al. Detection of M. tuberculosis in the environment as a tool for identifying high-risk locations for tuberculosis transmission. Sci Total Environ. 2022;843:156970.","journal-title":"Sci Total Environ"},{"issue":"11","key":"24858_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003578","volume":"4","author":"AJ Morton","year":"2024","unstructured":"Morton AJ, Roddy Mitchell A, Melville RE, Hui L, Tong SY, Dunstan SJ, et al. Mycobacterium tuberculosis infection in pregnancy: a systematic review. PLoS Glob Public Health. 2024;4(11):e0003578.","journal-title":"PLoS Glob Public Health"},{"key":"24858_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0077-2017","author":"S Ravimohan","year":"2018","unstructured":"Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018. https:\/\/doi.org\/10.1183\/16000617.0077-2017.","journal-title":"Eur Respir Rev"},{"issue":"10","key":"24858_CR9","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.21037\/tlcr-21-465","volume":"10","author":"K Xiong","year":"2021","unstructured":"Xiong K, Sun W, He Y, Fan L. Advances in molecular mechanisms of interaction between mycobacterium tuberculosis and lung cancer: a narrative review. Transl Lung Cancer Res. 2021;10(10):4012.","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"24858_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jdn.10116","volume":"81","author":"W Manjeese","year":"2021","unstructured":"Manjeese W, Mvubu NE, Steyn AJ, Mpofana T. Mycobacterium tuberculosis causes a leaky blood-brain barrier and neuroinflammation in the prefrontal cortex and cerebellum regions of infected mice offspring. Int J Dev Neurosci. 2021;81(5):428\u201337.","journal-title":"Int J Dev Neurosci"},{"issue":"7","key":"24858_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019435","volume":"10","author":"JP L\u00f3pez-L\u00f3pez","year":"2021","unstructured":"L\u00f3pez-L\u00f3pez JP, Posada-Mart\u00ednez EL, Saldarriaga C, Wyss F, Ponte-Negretti CI, Alexander B, et al. Tuberculosis and the heart. J Am Heart Assoc. 2021;10(7):e019435.","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"24858_CR12","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1016\/j.radcr.2022.06.019","volume":"17","author":"MAN Pramesti","year":"2022","unstructured":"Pramesti MAN, Atmaja MHS. Unusual spread of tb: a case report of hepatic tuberculosis. Radiol Case Rep. 2022;17(9):3281\u20135.","journal-title":"Radiol Case Rep"},{"issue":"5","key":"24858_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5312\/wjo.v14.i5.275","volume":"14","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana P, Leowattana T. Tuberculosis of the spine. World J Orthop. 2023;14(5):275.","journal-title":"World J Orthop"},{"issue":"1","key":"24858_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.2013.12-0413","volume":"88","author":"EDF Daher","year":"2013","unstructured":"Daher EDF, da Silva Junior GB, Barros EJG. Renal tuberculosis in the modern era. Am J Trop Med Hyg. 2013;88(1):54.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"24858_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jtbi.2003.11.023","volume":"227","author":"S Marino","year":"2004","unstructured":"Marino S, Kirschner DE. The human immune response to mycobacterium tuberculosis in lung and lymph node. J Theor Biol. 2004;227(4):463\u201386.","journal-title":"J Theor Biol"},{"issue":"12","key":"24858_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S1473-3099(21)00052-9","volume":"21","author":"K Rustage","year":"2021","unstructured":"Rustage K, Lobe J, Hayward SE, Kristensen KL, Margineanu I, Stienstra Y, et al. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(12):1701\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"1_suppl","key":"24858_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/00369330000450S105","volume":"45","author":"S Agarwal","year":"2000","unstructured":"Agarwal S. TB across the globe (2) tuberculosis in India\u2014the past and prospects for the future. Scott Med J. 2000;45(1_suppl):11\u20133.","journal-title":"Scott Med J"},{"issue":"1","key":"24858_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0974-777X.77287","volume":"3","author":"RO Onyango","year":"2011","unstructured":"Onyango RO. State of the globe: tracking tuberculosis is the test of time. J Glob Infect Dis. 2011;3(1):1\u20133.","journal-title":"J Glob Infect Dis"},{"issue":"1","key":"24858_CR19","first-page":"18","volume":"3","author":"H Mohajan","year":"2014","unstructured":"Mohajan H. Tuberculosis is a fatal disease among some developing countries of the world. American Journal of Infectious Diseases and Microbiology. 2014;3(1):18\u201331.","journal-title":"American Journal of Infectious Diseases and Microbiology"},{"issue":"4","key":"24858_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001758","volume":"3","author":"AV Easton","year":"2023","unstructured":"Easton AV, Salerno MM, Trieu L, Humphrey E, Kaba F, Macaraig M, et al. Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, march 2020 to june 2022. PLoS Glob Public Health. 2023;3(4):e0001758.","journal-title":"PLoS Glob Public Health"},{"key":"24858_CR21","unstructured":"Network GT, Casco N, Jorge AL, Palmero DJ, Alffenaar JW, Fox GJ, et\u00a0al. Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort. Eur Respir J. 2023;62(5)."},{"key":"24858_CR22","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S326383","author":"T Tolossa","year":"2021","unstructured":"Tolossa T, Tsegaye R, Shiferaw S, Wakuma B, Ayala D, Bekele B, et al. Survival from a triple co-infection of COVID-19, HIV, and tuberculosis: a case report. Int Med Case Rep J. 2021. https:\/\/doi.org\/10.2147\/IMCRJ.S326383","journal-title":"Int Med Case Rep J"},{"issue":"12","key":"24858_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/jama.1992.03490120095035","volume":"268","author":"KM De Cock","year":"1992","unstructured":"De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-saharan Africa. JAMA. 1992;268(12):1581\u20137.","journal-title":"JAMA"},{"issue":"1","key":"24858_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2017.1290317","volume":"10","author":"BJ Sullivan","year":"2017","unstructured":"Sullivan BJ, Esmaili BE, Cunningham CK. Barriers to initiating tuberculosis treatment in sub-saharan Africa: a systematic review focused on children and youth. Glob Health Action. 2017;10(1):1290317.","journal-title":"Glob Health Action"},{"issue":"9308","key":"24858_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0140-6736(02)07880-7","volume":"359","author":"MC Raviglione","year":"2002","unstructured":"Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948\u20132001. Lancet. 2002;359(9308):775\u201380.","journal-title":"Lancet"},{"issue":"9562","key":"24858_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(07)60316-X","volume":"369","author":"L Wang","year":"2007","unstructured":"Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet. 2007;369(9562):691\u20136.","journal-title":"Lancet"},{"issue":"7","key":"24858_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2105\/AJPH.88.7.1105","volume":"88","author":"AL Fairchild","year":"1998","unstructured":"Fairchild AL, Oppenheimer GM. Public health nihilism vs pragmatism: history, politics, and the control of tuberculosis. Am J Public Health. 1998;88(7):1105\u201317.","journal-title":"Am J Public Health"},{"issue":"1","key":"24858_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.medj.2021.11.006","volume":"3","author":"TP Setiabudiawan","year":"2022","unstructured":"Setiabudiawan TP, Reurink RK, Hill PC, Netea MG, van Crevel R, Koeken VA. Protection against tuberculosis by bacillus calmette-gu\u00e9rin (bcg) vaccination: a historical perspective. Med. 2022;3(1):6\u201324.","journal-title":"Med"},{"issue":"2","key":"24858_CR29","first-page":"458","volume":"8","author":"AS Bhadauria","year":"2023","unstructured":"Bhadauria AS, Dhungana HN, Verma V, Woodcock S, Rai T. Studying the efficacy of isolation as a control strategy and elimination of tuberculosis in India: a mathematical model. Infect Dis Model. 2023;8(2):458\u201370.","journal-title":"Infect Dis Model"},{"key":"24858_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-017-0239-4","volume":"16","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu J, Liao S, Sun Z. Treating tuberculosis with high doses of anti-tb drugs: mechanisms and outcomes. Ann Clin Microbiol Antimicrob. 2017;16:1\u201313.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9209","key":"24858_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0140-6736(00)02048-1","volume":"355","author":"TR Frieden","year":"2000","unstructured":"Frieden TR, Lerner BH, Rutherford BR. Lessons from the 1800s: tuberculosis control in the new millennium. Lancet. 2000;355(9209):1088\u201392.","journal-title":"Lancet"},{"key":"24858_CR32","doi-asserted-by":"crossref","unstructured":"McMillen CW. Discovering tuberculosis: a global history, 1900 to the present. Yale University Press; 2015.","DOI":"10.12987\/yale\/9780300190298.001.0001"},{"issue":"10","key":"24858_CR33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nri1704","volume":"5","author":"P Nunn","year":"2005","unstructured":"Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005;5(10):819\u201326.","journal-title":"Nat Rev Immunol"},{"issue":"1\u20133","key":"24858_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1472-9792(02)00071-9","volume":"83","author":"MC Raviglione","year":"2003","unstructured":"Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis. 2003;83(1\u20133):4\u201314.","journal-title":"Tuberculosis"},{"issue":"9","key":"24858_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092277","volume":"11","author":"G Mancuso","year":"2023","unstructured":"Mancuso G, Midiri A, De Gaetano S, Ponzo E, Biondo C. Tackling drug-resistant tuberculosis: new challenges from the old pathogen Mycobacterium tuberculosis. Microorganisms. 2023;11(9):2277.","journal-title":"Microorganisms"},{"key":"24858_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","volume":"42","author":"A Koch","year":"2018","unstructured":"Koch A, Cox H, Mizrahi V. Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Curr Opin Pharmacol. 2018;42:7\u201315.","journal-title":"Curr Opin Pharmacol"},{"key":"24858_CR37","doi-asserted-by":"crossref","unstructured":"Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, Mchugh TD, et\u00a0al. Drug-resistant tuberculosis\u2014current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis. 2012;205(suppl_2):S228\u201340.","DOI":"10.1093\/infdis\/jir858"},{"issue":"1","key":"24858_CR38","first-page":"9","volume":"18","author":"M Frick","year":"2016","unstructured":"Frick M, Henry I, Lessem E. Falling short of the rights to health and scientific progress: inadequate tb drug research and access. Health Hum Rights. 2016;18(1):9.","journal-title":"Health Hum Rights"},{"issue":"4","key":"24858_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/resp.12067","volume":"18","author":"CY Chiang","year":"2013","unstructured":"Chiang CY, Van Weezenbeek C, Mori T, Enarson DA. Challenges to the global control of tuberculosis. Respirology. 2013;18(4):596\u2013604.","journal-title":"Respirology"},{"key":"24858_CR40","first-page":"489","volume":"80","author":"A Pablos-Mendez","year":"2002","unstructured":"Pablos-Mendez A, Gowda DK, Frieden TR. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bull World Health Organ. 2002;80:489\u201395.","journal-title":"Bull World Health Organ"},{"key":"24858_CR41","doi-asserted-by":"crossref","unstructured":"Loddenkemper R, Konietzko N. Tuberculosis in Germany before, during and after World War II. In: Tuberculosis and War, vol.\u00a043. Karger Publishers; 2018. pp. 64\u201385.","DOI":"10.1159\/000481475"},{"issue":"11","key":"24858_CR42","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3201\/eid2111.141894","volume":"21","author":"JH Kim","year":"2015","unstructured":"Kim JH, Yim JJ. Achievements in and challenges of tuberculosis control in South Korea. Emerg Infect Dis. 2015;21(11):1913\u201320.","journal-title":"Emerg Infect Dis"},{"key":"24858_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijid.2019.10.015","volume":"90","author":"A Abbara","year":"2020","unstructured":"Abbara A, Almalla M, AlMasri I, AlKabbani H, Karah N, El-Amin W, et al. The challenges of tuberculosis control in protracted conflict: the case of Syria. Int J Infect Dis. 2020;90:53\u20139.","journal-title":"Int J Infect Dis"},{"key":"24858_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-2338-5","volume":"15","author":"TTT Hoang","year":"2015","unstructured":"Hoang TTT, Nguyen NV, Dinh SN, Nguyen HB, Cobelens F, Thwaites G, et al. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. BMC Public Health. 2015;15:1\u201310.","journal-title":"BMC Public Health"},{"issue":"9","key":"24858_CR45","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3906\/sag-2004-127","volume":"50","author":"M Has\u00f6ks\u00fcz","year":"2020","unstructured":"Has\u00f6ks\u00fcz M, Kilic S, Sara\u00e7 F. Coronaviruses and SARS-CoV-2. Turk J Med Sci. 2020;50(9):549\u201356.","journal-title":"Turk J Med Sci"},{"key":"24858_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104795","volume":"137","author":"M Redlberger-Fritz","year":"2021","unstructured":"Redlberger-Fritz M, Kundi M, Aberle SW, Puchhammer-St\u00f6ckl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021;137:104795.","journal-title":"J Clin Virol"},{"issue":"5","key":"24858_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/v14051075","volume":"14","author":"M D\u00f6hla","year":"2022","unstructured":"D\u00f6hla M, Schulte B, Wilbring G, K\u00fcmmerer BM, D\u00f6hla C, Sib E, et al. Sars-cov-2 in environmental samples of quarantined households. Viruses. 2022;14(5):1075.","journal-title":"Viruses"},{"key":"24858_CR48","doi-asserted-by":"crossref","unstructured":"Raffle AE, Pollock AM, Harding-Edgar L. Covid-19 mass testing programmes. BMJ. 2020;370.","DOI":"10.1136\/bmj.m3262"},{"issue":"6498","key":"24858_CR49","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1126\/science.abc6197","volume":"368","author":"KA Prather","year":"2020","unstructured":"Prather KA, Wang CC, Schooley RT. Reducing transmission of sars-cov-2. Science. 2020;368(6498):1422\u20134.","journal-title":"Science"},{"issue":"6","key":"24858_CR50","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5588\/ijtld.21.0148","volume":"25","author":"CF McQuaid","year":"2021","unstructured":"McQuaid CF, Vassall A, Cohen T, Fiekert K, White R, et al. The impact of covid-19 on tb: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436\u201346.","journal-title":"Int J Tuberc Lung Dis"},{"key":"24858_CR51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01786-2021","author":"GB Migliori","year":"2021","unstructured":"Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, et al. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.01786-2021.","journal-title":"Eur Respir J"},{"key":"24858_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-020-00363-1","volume":"19","author":"T Togun","year":"2020","unstructured":"Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the covid-19 pandemic on tb patients and tb control programmes. Ann Clin Microbiol Antimicrob. 2020;19:1\u20136.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"24858_CR53","volume":"2022","author":"S Kratzer","year":"2022","unstructured":"Kratzer S, Pfadenhauer LM, Biallas RL, Featherstone R, Klinger C, Movsisyan A, et al. Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review. Cochrane Database Syst Rev. 2022;2022(6):CD015397.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"24858_CR54","doi-asserted-by":"publisher","first-page":"e1357","DOI":"10.1016\/S2214-109X(20)30413-7","volume":"8","author":"KH Keddy","year":"2020","unstructured":"Keddy KH, Migliori GB, Van der Walt M. Developing health policies in patients presenting with sars-cov-2: consider tuberculosis. Lancet Glob Health. 2020;8(11):e1357\u20138.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"24858_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed4010028","volume":"4","author":"CA John","year":"2019","unstructured":"John CA. Realizing the world health organization\u2019s end tb strategy (2016\u20132035): how can social approaches to tuberculosis elimination contribute to progress in Asia and the Pacific? Trop Med Infect Dis. 2019;4(1):28.","journal-title":"Trop Med Infect Dis"},{"key":"24858_CR56","unstructured":"Organization WH. Global tuberculosis report 2024. World Health Organization; 2024."},{"key":"24858_CR57","unstructured":"World Health Organization. Framework for Implementing the \u201cEnd TB Strategy\u201d in the African Region 2016\u20132020. World Health Organization, Regional Office for Africa; 2017. https:\/\/www.afro.who.int\/publications\/framework-implementing-end-tb-strategy-african-region-2016-2020. Accessed 2 June 2025."},{"issue":"6","key":"24858_CR58","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S2213-2600(22)00092-3","volume":"10","author":"K Dheda","year":"2022","unstructured":"Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott AJ, et al. The intersecting pandemics of tuberculosis and covid-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022;10(6):603\u201322.","journal-title":"Lancet Respir Med"},{"key":"24858_CR59","unstructured":"Centers for Disease Control and Prevention. Tuberculosis Surveillance Report 2023. U.S. Centers for Disease Control and Prevention. 2023. https:\/\/www.cdc.gov\/tb-surveillance-report-2023\/summary\/index.html. Accessed 30 Mar 2025."},{"key":"24858_CR60","unstructured":"News-Medical. Four breakthrough studies could revolutionize tuberculosis treatment; 2025. https:\/\/www.news-medical.net\/news\/20250322\/Four-breakthrough-studies-could-revolutionize-tuberculosis-treatment.aspx. Accessed 30 Mar 2025."},{"key":"24858_CR61","unstructured":"World Health Organization. The Untold Story: New Report Reveals 7000 Additional TB Deaths During COVID-19 Pandemic. 2024. https:\/\/www.who.int\/europe\/news-room\/21-03-2024-the-untold-story--new-report-reveals-7000-additional-tb-deaths-during-covid-19-pandemic?utm_source=chatgpt.com. Accessed 30 Mar 2025."},{"key":"24858_CR62","unstructured":"European Centre for Disease Prevention and Control. The Untold Story: New Report Reveals 7000 Additional TB Deaths During COVID-19 Pandemic. 2024. https:\/\/www.ecdc.europa.eu\/en\/news-events\/untold-story-new-report-reveals-7000-additional-tb-deaths-during-covid-19-pandemic?utm_source=chatgpt.com. Accessed 30 Mar 2025."},{"issue":"1","key":"24858_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-022-00145-0","volume":"2","author":"M Tovar","year":"2022","unstructured":"Tovar M, Aleta A, Sanz J, Moreno Y. Modeling the impact of COVID-19 on future tuberculosis burden. Commun Med. 2022;2(1):77.","journal-title":"Commun Med"},{"issue":"2","key":"24858_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.46234\/ccdcw2021.004","volume":"3","author":"C Xu","year":"2021","unstructured":"Xu C, Li T, Hu D, Zhang H, Zhao Y, Liu J. Predicted impact of the covid-19 responses on deaths of tuberculosis-China, 2020. China CDC Wkly. 2021;3(2):21.","journal-title":"China CDC Wkly"},{"key":"24858_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100603","author":"L Cilloni","year":"2020","unstructured":"Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100603.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"24858_CR66","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1016\/S2214-109X(20)30288-6","volume":"8","author":"AB Hogan","year":"2020","unstructured":"Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the covid-19 pandemic on hiv, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132\u201341.","journal-title":"Lancet Glob Health"},{"key":"24858_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.idm.2024.02.001","author":"G Chowell","year":"2024","unstructured":"Chowell G, Dahal S, Bleichrodt A, Tariq A, Hyman JM, Luo R. Subepipredict: a tutorial-based primer and toolbox for fitting and forecasting growth trajectories using the ensemble n-sub-epidemic modeling framework. Infect Dis Model. 2024. https:\/\/doi.org\/10.1016\/j.idm.2024.02.001.","journal-title":"Infect Dis Model"},{"key":"24858_CR68","unstructured":"Roser M. What is the COVID-19 Stringency Index? Our World in Data. 2021. https:\/\/ourworldindata.org\/metrics-explained-covid19-stringency-index."},{"issue":"1","key":"24858_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-024-01247-8","volume":"13","author":"H Lv","year":"2024","unstructured":"Lv H, Wang L, Zhang X, Dang C, Liu F, Zhang X, et al. Further analysis of tuberculosis in eight high-burden countries based on the global burden of disease study 2021 data. Infect Dis Poverty. 2024;13(1):70.","journal-title":"Infect Dis Poverty"},{"key":"24858_CR70","unstructured":"Roser M. What is the COVID-19 Stringency Index? Our World in Data. 2021."},{"key":"24858_CR71","unstructured":"Collaborators of the Global Burden of Disease Study. Global Burden of Disease Study 2021 (GBD 2021) Socio-Demographic Index (SDI) 1950\u20132021. Institute for Health Metrics and Evaluation (IHME); 2021."},{"issue":"10","key":"24858_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010602","volume":"18","author":"G Chowell","year":"2022","unstructured":"Chowell G, Dahal S, Tariq A, Roosa K, Hyman JM, Luo R. An ensemble n-sub-epidemic modeling framework for short-term forecasting epidemic trajectories: application to the covid-19 pandemic in the USA. PLoS Comput Biol. 2022;18(10):e1010602.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"24858_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/biomet\/76.2.297","volume":"76","author":"CM Hurvich","year":"1989","unstructured":"Hurvich CM, Tsai CL. Regression and time series model selection in small samples. Biometrika. 1989;76(2):297\u2013307.","journal-title":"Biometrika"},{"issue":"1","key":"24858_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/03610927808827599","volume":"7","author":"N Sugiura","year":"1978","unstructured":"Sugiura N. Further analysis of the data by Akaike\u2019s information criterion and the finite corrections: further analysis of the data by Akaike\u2019s. Commun Stat. 1978;7(1):13\u201326.","journal-title":"Commun Stat"},{"issue":"1","key":"24858_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-022-00729-9","volume":"46","author":"ED Jacobs","year":"2022","unstructured":"Jacobs ED, Okeke MI. A critical evaluation of Nigeria\u2019s response to the first wave of covid-19. Bull Natl Res Cent. 2022;46(1):44.","journal-title":"Bull Natl Res Cent"},{"issue":"6","key":"24858_CR76","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S2213-2600(21)00161-2","volume":"9","author":"T Wingfield","year":"2021","unstructured":"Wingfield T, Karmadwala F, MacPherson P, Millington KA, Walker NF, Cuevas LE, et al. Challenges and opportunities to end tuberculosis in the COVID-19 era. Lancet Respir Med. 2021;9(6):556.","journal-title":"Lancet Respir Med"},{"key":"24858_CR77","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4054\/DemRes.2025.52.23","volume":"52","author":"H Gaddy","year":"2025","unstructured":"Gaddy H, Gargiulo M. Can we estimate crisis death tolls by subtracting total population estimates? A critical review and appraisal. Demogr Res. 2025;52:741\u201396.","journal-title":"Demogr Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24858-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:06:36Z","timestamp":1761908796000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24858-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24858"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24858-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6806070\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and informed consent were not required for this study, as it relies exclusively on publicly available, aggregated, and de-identified data from global sources, including the World Health Organization (WHO), the Oxford COVID-19 Government Response Tracker, the Global Health Security Index, and the Global Burden of Disease Study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3723"}}